SE0104295D0 - New process - Google Patents

New process

Info

Publication number
SE0104295D0
SE0104295D0 SE0104295A SE0104295A SE0104295D0 SE 0104295 D0 SE0104295 D0 SE 0104295D0 SE 0104295 A SE0104295 A SE 0104295A SE 0104295 A SE0104295 A SE 0104295A SE 0104295 D0 SE0104295 D0 SE 0104295D0
Authority
SE
Sweden
Prior art keywords
preparation
relates
new process
rabeprazole
pantoprazole
Prior art date
Application number
SE0104295A
Other languages
English (en)
Inventor
Shalini Andersson
Marcus Juza
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0104295A priority Critical patent/SE0104295D0/sv
Publication of SE0104295D0 publication Critical patent/SE0104295D0/sv
Priority to CA002468688A priority patent/CA2468688A1/en
Priority to JP2003552751A priority patent/JP2005517656A/ja
Priority to EP02793664A priority patent/EP1458709A1/en
Priority to PCT/SE2002/002356 priority patent/WO2003051867A1/en
Priority to AU2002359151A priority patent/AU2002359151A1/en
Priority to US10/498,944 priority patent/US20050049282A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0104295A 2001-12-18 2001-12-18 New process SE0104295D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE0104295A SE0104295D0 (sv) 2001-12-18 2001-12-18 New process
CA002468688A CA2468688A1 (en) 2001-12-18 2002-12-17 New process
JP2003552751A JP2005517656A (ja) 2001-12-18 2002-12-17 新規な方法
EP02793664A EP1458709A1 (en) 2001-12-18 2002-12-17 New process
PCT/SE2002/002356 WO2003051867A1 (en) 2001-12-18 2002-12-17 New process
AU2002359151A AU2002359151A1 (en) 2001-12-18 2002-12-17 New process
US10/498,944 US20050049282A1 (en) 2001-12-18 2002-12-17 Process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0104295A SE0104295D0 (sv) 2001-12-18 2001-12-18 New process

Publications (1)

Publication Number Publication Date
SE0104295D0 true SE0104295D0 (sv) 2001-12-18

Family

ID=20286395

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0104295A SE0104295D0 (sv) 2001-12-18 2001-12-18 New process

Country Status (7)

Country Link
US (1) US20050049282A1 (sv)
EP (1) EP1458709A1 (sv)
JP (1) JP2005517656A (sv)
AU (1) AU2002359151A1 (sv)
CA (1) CA2468688A1 (sv)
SE (1) SE0104295D0 (sv)
WO (1) WO2003051867A1 (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100348595C (zh) * 2005-03-17 2007-11-14 浙江大学宁波理工学院 奥美拉唑对映体的模拟移动床色谱分离方法
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7553857B2 (en) 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
US8404853B2 (en) 2006-07-05 2013-03-26 Lupin Limited Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds
EP1947099A1 (en) 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Process for solvent removal from omeprazole salts
EA200900985A1 (ru) 2007-01-31 2009-12-30 Крка, Товарна Здравил, Д. Д., Ново Место Способ получения оптически чистого омепразола
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
EP2143722A1 (en) 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
CN102143789B (zh) * 2008-08-26 2013-12-25 大赛璐化学工业株式会社 使用模拟移动床色谱分离装置制造目标物质的方法
US20100113527A1 (en) * 2008-09-30 2010-05-06 Teva Pharmaceutical Industries Ltd. Crystalline forms of dexlansoprazole
KR101001646B1 (ko) * 2008-12-12 2010-12-17 한미약품 주식회사 (r)-(+)-란소프라졸의 제조방법 및 이에 사용되는 중간체
EP2522647B1 (en) 2011-05-10 2014-04-30 DSM IP Assets B.V. Process of separating chiral isomers of chroman compounds and their derivatives and precursors
EP2573063A1 (en) 2011-09-23 2013-03-27 DSM IP Assets B.V. Process for preparing chiral quinone
CN103193572B (zh) * 2013-04-07 2015-06-17 山东大学 一种拉唑类化合物单一对映体的分离方法
US20180155311A1 (en) 2015-05-26 2018-06-07 Dsm Ip Assets B.V. Separation of chiral isomers by sfc
CN106928190A (zh) * 2015-12-29 2017-07-07 中美华世通生物医药科技(武汉)有限公司 利用模拟移动床色谱分离制备兰索拉唑的方法
CN106390519A (zh) * 2016-09-12 2017-02-15 华东理工大学 多柱模拟移动床色谱技术连续分离氨鲁米特外消旋体的方法
JP7335002B2 (ja) * 2019-08-29 2023-08-29 学校法人東京理科大学 スルホキシド化合物のエナンチオマー調製方法及びエナンチオマー調製システム

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2985589A (en) * 1957-05-22 1961-05-23 Universal Oil Prod Co Continuous sorption process employing fixed bed of sorbent and moving inlets and outlets
US2957927A (en) * 1957-06-27 1960-10-25 Universal Oil Prod Co Process for separating normal aliphatic hydrocarbons from hydrocarbon mixtures
NL293774A (sv) * 1962-06-08
US3291726A (en) * 1964-05-04 1966-12-13 Universal Oil Prod Co Continuous simulated countercurrent sorption process employing desorbent made in said process
US3310486A (en) * 1964-08-13 1967-03-21 Universal Oil Prod Co Separation process for the recovery of high purity components of hydrocarbon mixtures
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (sv) * 1986-11-13 1994-02-25 Eisai Co Ltd Förfarande för framställning såsom läkemedel användbara 2-pyridin-2-yl-metyltio- och sulfinyl-1H-benzimidazolderivater
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
WO2000071539A1 (en) * 1999-05-26 2000-11-30 Pharm-Eco Laboratories Inc. Methods of separating ftc isomers and derivatives thereof

Also Published As

Publication number Publication date
WO2003051867A1 (en) 2003-06-26
US20050049282A1 (en) 2005-03-03
EP1458709A1 (en) 2004-09-22
CA2468688A1 (en) 2003-06-26
AU2002359151A1 (en) 2003-06-30
JP2005517656A (ja) 2005-06-16

Similar Documents

Publication Publication Date Title
SE0104295D0 (sv) New process
EE200100248A (et) Omeprasooli uus kristalne vorm
SE9900274D0 (sv) New compound
WO1998054171A8 (en) Novel form of s-omeprazole
SE9702483D0 (sv) New compound
MXPA04000433A (es) Procedimiento mejorado para preparar compuestos tipo bencimidazol.
DK1598340T3 (da) 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazol -2-on derivater og beslægtede forbindelser som nociceptin analoger og ORL1 ligander til behandling af smerte
IS6897A (is) Aðferðir til að framleiða útskipt 2-(2-pýridýlmetýl)súlfinýl-1H-bensimídasól
ZA989999B (en) New process for the preparation of 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)1H-benzimidazole
WO2011042910A3 (en) Optical resolution of substituted 2-(2- pyridinylmethylsulphinyl)-1h-benzimidazoles
SE0302382D0 (sv) New salts II
SE0302381D0 (sv) New salts I
DK1591122T3 (da) Fremgangsmåde til indgivelse af bisphosphonater
DE60113161D1 (de) Verfahren zur herstellung von 2-(4-pyridyl)amino-6-dialkylolxaphenyl-pyrido(2,3-d)pyrimidon-7-on-derivaten
DE60029493D1 (de) Neues verfahren zur herstellung von 1-phenyl-2-(2-pyridyl)ethanamin
DK1490363T3 (da) Fremgangsmåder til fremstilling af 2-7-chlor-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)1-isoindolinon
DK1615902T3 (da) Fremgangsmåde til fremstilling af 4, 10beta-diacetoxy-2alfa-benzoyloxy-5beta,20-epoxy-1,13alfa-dihydroxy-9-oxo-19-norcyclopropa(g)tax-11-en
DK1285913T3 (da) Fremgangsmåde til fremstilling af 3,5-dichlorpyridin
YU32301A (sh) Novi kristalni oblik omeprazola
EA201190084A1 (ru) Способ получения эзомепразола
ECSP003736A (es) Procedimiento mejorado para la preparacion de derivados de bencimidazol adecuados como farmacos antiulcerosos, particularmente omeprazol o pantoprazol
UY26420A1 (es) Procedimiento mejorado para la preparación de derivados bencimidazol adecuados como fármacos antiulcerosos, particularmente omeprazol o pantoprazol